nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—HRH1—nose—brain cancer	0.209	0.215	CbGeAlD
Tolazoline—ADRA1A—hindbrain—brain cancer	0.0581	0.0597	CbGeAlD
Tolazoline—HRH2—endocrine gland—brain cancer	0.038	0.039	CbGeAlD
Tolazoline—HRH2—head—brain cancer	0.0375	0.0385	CbGeAlD
Tolazoline—HRH2—central nervous system—brain cancer	0.0342	0.0352	CbGeAlD
Tolazoline—ADRA1A—brainstem—brain cancer	0.0333	0.0342	CbGeAlD
Tolazoline—ADRA1A—telencephalon—brain cancer	0.0295	0.0304	CbGeAlD
Tolazoline—ADRA2C—telencephalon—brain cancer	0.0281	0.0289	CbGeAlD
Tolazoline—HRH2—brain—brain cancer	0.0272	0.0279	CbGeAlD
Tolazoline—ADRA2C—pituitary gland—brain cancer	0.0229	0.0236	CbGeAlD
Tolazoline—HRH1—telencephalon—brain cancer	0.0229	0.0235	CbGeAlD
Tolazoline—ADRA2A—telencephalon—brain cancer	0.0225	0.0231	CbGeAlD
Tolazoline—ADRA2C—medulla oblongata—brain cancer	0.0221	0.0227	CbGeAlD
Tolazoline—ADRA2C—midbrain—brain cancer	0.0202	0.0208	CbGeAlD
Tolazoline—ADRA2C—spinal cord—brain cancer	0.0197	0.0203	CbGeAlD
Tolazoline—ADRA2A—gonad—brain cancer	0.0187	0.0193	CbGeAlD
Tolazoline—ADRA1A—endocrine gland—brain cancer	0.0186	0.0191	CbGeAlD
Tolazoline—ADRA1A—head—brain cancer	0.0184	0.0189	CbGeAlD
Tolazoline—ADRA2A—pituitary gland—brain cancer	0.0183	0.0188	CbGeAlD
Tolazoline—ADRA2A—medulla oblongata—brain cancer	0.0176	0.0181	CbGeAlD
Tolazoline—ADRA2C—head—brain cancer	0.0175	0.018	CbGeAlD
Tolazoline—ADRA1A—central nervous system—brain cancer	0.0168	0.0173	CbGeAlD
Tolazoline—ADRA1A—cerebellum—brain cancer	0.0164	0.0169	CbGeAlD
Tolazoline—ADRA2A—midbrain—brain cancer	0.0161	0.0166	CbGeAlD
Tolazoline—ADRA2C—central nervous system—brain cancer	0.016	0.0164	CbGeAlD
Tolazoline—ADRA2A—spinal cord—brain cancer	0.0157	0.0162	CbGeAlD
Tolazoline—ADRA2C—cerebellum—brain cancer	0.0156	0.0161	CbGeAlD
Tolazoline—HRH1—endocrine gland—brain cancer	0.0144	0.0148	CbGeAlD
Tolazoline—HRH1—head—brain cancer	0.0142	0.0146	CbGeAlD
Tolazoline—ADRA2A—endocrine gland—brain cancer	0.0142	0.0146	CbGeAlD
Tolazoline—ADRA2A—head—brain cancer	0.014	0.0144	CbGeAlD
Tolazoline—ADRA1A—brain—brain cancer	0.0133	0.0137	CbGeAlD
Tolazoline—HRH1—central nervous system—brain cancer	0.013	0.0134	CbGeAlD
Tolazoline—ADRA2A—central nervous system—brain cancer	0.0128	0.0131	CbGeAlD
Tolazoline—ADRA2C—brain—brain cancer	0.0127	0.0131	CbGeAlD
Tolazoline—ADRA2A—cerebellum—brain cancer	0.0125	0.0128	CbGeAlD
Tolazoline—HRH1—brain—brain cancer	0.0103	0.0106	CbGeAlD
Tolazoline—ADRA2A—brain—brain cancer	0.0101	0.0104	CbGeAlD
Tolazoline—ADRA2C—Signaling by GPCR—TRPC6—brain cancer	4.32e-05	0.00158	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ABR—brain cancer	4.32e-05	0.00158	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—STRADA—brain cancer	4.3e-05	0.00157	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—SMO—brain cancer	4.25e-05	0.00155	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—PTCH1—brain cancer	4.25e-05	0.00155	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—TRPC6—brain cancer	4.24e-05	0.00155	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—STRADA—brain cancer	4.22e-05	0.00154	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PTCH2—brain cancer	4.17e-05	0.00152	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GLI2—brain cancer	4.17e-05	0.00152	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—TRPC6—brain cancer	4.16e-05	0.00152	CbGpPWpGaD
Tolazoline—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—brain cancer	4.15e-05	0.00152	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—PIK3CG—brain cancer	4.12e-05	0.00151	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HES5—brain cancer	4.04e-05	0.00148	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ABR—brain cancer	4.03e-05	0.00147	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—IDH1—brain cancer	4e-05	0.00146	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—SHH—brain cancer	3.99e-05	0.00146	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—IL2—brain cancer	3.97e-05	0.00145	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—STRADA—brain cancer	3.92e-05	0.00143	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GLI1—brain cancer	3.92e-05	0.00143	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—SHH—brain cancer	3.92e-05	0.00143	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GLI2—brain cancer	3.89e-05	0.00142	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—TRPC6—brain cancer	3.86e-05	0.00141	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—TRPC6—brain cancer	3.85e-05	0.00141	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—PIK3CG—brain cancer	3.83e-05	0.0014	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—VAV1—brain cancer	3.82e-05	0.00139	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—SMO—brain cancer	3.78e-05	0.00138	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PTCH1—brain cancer	3.78e-05	0.00138	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—BSG—brain cancer	3.78e-05	0.00138	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—TRPC6—brain cancer	3.78e-05	0.00138	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—PIK3CG—brain cancer	3.74e-05	0.00137	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SUFU—brain cancer	3.71e-05	0.00136	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PTCH1—brain cancer	3.71e-05	0.00136	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—SMO—brain cancer	3.71e-05	0.00136	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GLI1—brain cancer	3.66e-05	0.00134	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—NOTCH2—brain cancer	3.65e-05	0.00133	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—SHH—brain cancer	3.64e-05	0.00133	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ABR—brain cancer	3.59e-05	0.00131	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GFAP—brain cancer	3.58e-05	0.00131	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—PIK3CG—brain cancer	3.58e-05	0.00131	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—VAV1—brain cancer	3.56e-05	0.0013	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ABR—brain cancer	3.52e-05	0.00129	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—TRPC6—brain cancer	3.51e-05	0.00128	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—VAV1—brain cancer	3.48e-05	0.00127	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SUFU—brain cancer	3.47e-05	0.00127	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GLI2—brain cancer	3.47e-05	0.00127	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—VAV1—brain cancer	3.46e-05	0.00127	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—SMO—brain cancer	3.45e-05	0.00126	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PTCH1—brain cancer	3.45e-05	0.00126	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.4e-05	0.00124	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GLI2—brain cancer	3.4e-05	0.00124	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HEY1—brain cancer	3.4e-05	0.00124	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—brain cancer	3.37e-05	0.00123	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GFAP—brain cancer	3.35e-05	0.00122	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.34e-05	0.00122	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—DLL1—brain cancer	3.33e-05	0.00122	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ABR—brain cancer	3.27e-05	0.0012	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GLI1—brain cancer	3.26e-05	0.00119	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—IDH1—brain cancer	3.25e-05	0.00119	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—VAV1—brain cancer	3.24e-05	0.00118	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GLI1—brain cancer	3.2e-05	0.00117	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—VAV1—brain cancer	3.17e-05	0.00116	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HEY1—brain cancer	3.17e-05	0.00116	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ENO2—brain cancer	3.16e-05	0.00116	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GLI2—brain cancer	3.16e-05	0.00116	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	3.12e-05	0.00114	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—DLL1—brain cancer	3.11e-05	0.00114	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SUFU—brain cancer	3.09e-05	0.00113	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SUFU—brain cancer	3.03e-05	0.00111	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—HES1—brain cancer	2.99e-05	0.00109	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GFAP—brain cancer	2.98e-05	0.00109	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GLI1—brain cancer	2.97e-05	0.00109	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GFAP—brain cancer	2.93e-05	0.00107	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—PIK3CG—brain cancer	2.91e-05	0.00106	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—IL2—brain cancer	2.9e-05	0.00106	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—VAV1—brain cancer	2.89e-05	0.00106	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—VAV1—brain cancer	2.88e-05	0.00105	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—PDGFRA—brain cancer	2.85e-05	0.00104	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SHH—brain cancer	2.83e-05	0.00104	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—VAV1—brain cancer	2.83e-05	0.00103	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HEY1—brain cancer	2.83e-05	0.00103	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SUFU—brain cancer	2.82e-05	0.00103	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HEY1—brain cancer	2.77e-05	0.00101	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—DLL1—brain cancer	2.77e-05	0.00101	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—SPP1—brain cancer	2.77e-05	0.00101	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TRPC6—brain cancer	2.73e-05	0.000998	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—DLL1—brain cancer	2.72e-05	0.000994	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GFAP—brain cancer	2.72e-05	0.000994	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—IL2—brain cancer	2.7e-05	0.000986	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SMO—brain cancer	2.69e-05	0.000981	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PTCH1—brain cancer	2.69e-05	0.000981	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SHH—brain cancer	2.65e-05	0.000967	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—IL2—brain cancer	2.63e-05	0.000962	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—VAV1—brain cancer	2.63e-05	0.000961	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HEY1—brain cancer	2.58e-05	0.000942	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ENO2—brain cancer	2.57e-05	0.000939	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TRPC6—brain cancer	2.55e-05	0.000933	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—DLL1—brain cancer	2.53e-05	0.000924	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—IL2—brain cancer	2.52e-05	0.000921	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PTCH1—brain cancer	2.51e-05	0.000917	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SMO—brain cancer	2.51e-05	0.000917	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IRS2—brain cancer	2.5e-05	0.000914	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—PIK3CG—brain cancer	2.42e-05	0.000885	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SHH—brain cancer	2.36e-05	0.000862	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SHH—brain cancer	2.31e-05	0.000845	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—VEGFA—brain cancer	2.29e-05	0.000838	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TRPC6—brain cancer	2.27e-05	0.000831	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—PIK3CG—brain cancer	2.26e-05	0.000827	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SMO—brain cancer	2.23e-05	0.000817	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PTCH1—brain cancer	2.23e-05	0.000817	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TRPC6—brain cancer	2.23e-05	0.000815	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—APC—brain cancer	2.21e-05	0.000808	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—PIK3CG—brain cancer	2.21e-05	0.000808	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—PIK3CG—brain cancer	2.2e-05	0.000804	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SMO—brain cancer	2.19e-05	0.000801	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PTCH1—brain cancer	2.19e-05	0.000801	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SHH—brain cancer	2.15e-05	0.000786	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NOTCH2—brain cancer	2.15e-05	0.000785	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—VEGFA—brain cancer	2.14e-05	0.000783	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TRPC6—brain cancer	2.07e-05	0.000757	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—PIK3CG—brain cancer	2.05e-05	0.000751	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—VAV1—brain cancer	2.05e-05	0.000748	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—IL2—brain cancer	2.05e-05	0.000748	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PTCH1—brain cancer	2.04e-05	0.000745	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SMO—brain cancer	2.04e-05	0.000745	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	2.02e-05	0.000737	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—EGFR—brain cancer	2.01e-05	0.000736	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NOTCH2—brain cancer	2.01e-05	0.000733	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	1.98e-05	0.000723	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—VAV1—brain cancer	1.91e-05	0.000699	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	1.84e-05	0.000672	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PIK3CG—brain cancer	1.83e-05	0.000669	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	1.8e-05	0.000657	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.79e-05	0.000653	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HES1—brain cancer	1.76e-05	0.000643	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	1.75e-05	0.000641	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—VEGFA—brain cancer	1.74e-05	0.000636	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—TP53—brain cancer	1.73e-05	0.000633	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—RELA—brain cancer	1.73e-05	0.000631	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—ERBB2—brain cancer	1.72e-05	0.000627	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—IL2—brain cancer	1.7e-05	0.000623	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—VAV1—brain cancer	1.7e-05	0.000622	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	1.68e-05	0.000613	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—VAV1—brain cancer	1.67e-05	0.000611	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	1.67e-05	0.00061	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HES1—brain cancer	1.64e-05	0.000601	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	1.63e-05	0.000595	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SPP1—brain cancer	1.63e-05	0.000595	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—TP53—brain cancer	1.62e-05	0.000591	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—IL2—brain cancer	1.59e-05	0.000582	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	1.57e-05	0.000572	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL2—brain cancer	1.56e-05	0.000568	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—VAV1—brain cancer	1.55e-05	0.000568	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL2—brain cancer	1.55e-05	0.000566	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SPP1—brain cancer	1.52e-05	0.000555	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CCND1—brain cancer	1.52e-05	0.000554	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CTNNB1—brain cancer	1.5e-05	0.000549	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IRS2—brain cancer	1.47e-05	0.000538	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HES1—brain cancer	1.46e-05	0.000535	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CG—brain cancer	1.45e-05	0.000531	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL2—brain cancer	1.45e-05	0.000528	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HES1—brain cancer	1.44e-05	0.000525	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—IL2—brain cancer	1.42e-05	0.000518	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.39e-05	0.00051	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—IL2—brain cancer	1.39e-05	0.000509	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IRS2—brain cancer	1.37e-05	0.000502	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	1.37e-05	0.0005	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SPP1—brain cancer	1.35e-05	0.000495	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HES1—brain cancer	1.34e-05	0.000488	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.33e-05	0.000486	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—VEGFA—brain cancer	1.32e-05	0.000483	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—TP53—brain cancer	1.31e-05	0.00048	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—STAT3—brain cancer	1.31e-05	0.000478	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—APC—brain cancer	1.3e-05	0.000475	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	1.3e-05	0.000475	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—IL2—brain cancer	1.29e-05	0.000473	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL2—brain cancer	1.29e-05	0.000471	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	1.27e-05	0.000465	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL2—brain cancer	1.26e-05	0.000462	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SPP1—brain cancer	1.23e-05	0.000451	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IRS2—brain cancer	1.22e-05	0.000448	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MYC—brain cancer	1.22e-05	0.000444	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—APC—brain cancer	1.21e-05	0.000444	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	1.21e-05	0.000444	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.2e-05	0.000439	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—EGFR—brain cancer	1.19e-05	0.000435	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—EGFR—brain cancer	1.18e-05	0.000433	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CG—brain cancer	1.18e-05	0.000431	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.17e-05	0.000429	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.12e-05	0.000408	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—EGFR—brain cancer	1.11e-05	0.000404	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.08e-05	0.000395	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APC—brain cancer	1.08e-05	0.000395	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.06e-05	0.000388	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APC—brain cancer	1.06e-05	0.000388	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RELA—brain cancer	1.02e-05	0.000371	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ERBB2—brain cancer	1.01e-05	0.000369	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TP53—brain cancer	9.99e-06	0.000365	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	9.86e-06	0.00036	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APC—brain cancer	9.86e-06	0.00036	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—EGFR—brain cancer	9.85e-06	0.00036	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—EGFR—brain cancer	9.67e-06	0.000353	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RELA—brain cancer	9.49e-06	0.000347	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ERBB2—brain cancer	9.43e-06	0.000344	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL2—brain cancer	9.15e-06	0.000334	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—EGFR—brain cancer	8.98e-06	0.000328	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCND1—brain cancer	8.92e-06	0.000326	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	8.83e-06	0.000323	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL2—brain cancer	8.54e-06	0.000312	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RELA—brain cancer	8.45e-06	0.000309	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ERBB2—brain cancer	8.4e-06	0.000307	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCND1—brain cancer	8.33e-06	0.000304	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RELA—brain cancer	8.29e-06	0.000303	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	8.25e-06	0.000301	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ERBB2—brain cancer	8.24e-06	0.000301	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—VEGFA—brain cancer	7.77e-06	0.000284	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RELA—brain cancer	7.7e-06	0.000282	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—STAT3—brain cancer	7.7e-06	0.000281	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ERBB2—brain cancer	7.66e-06	0.00028	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL2—brain cancer	7.61e-06	0.000278	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL2—brain cancer	7.47e-06	0.000273	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCND1—brain cancer	7.42e-06	0.000271	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CTNNB1—brain cancer	7.35e-06	0.000268	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCND1—brain cancer	7.28e-06	0.000266	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—VEGFA—brain cancer	7.26e-06	0.000265	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	7.21e-06	0.000263	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—STAT3—brain cancer	7.19e-06	0.000263	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MYC—brain cancer	7.15e-06	0.000261	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EGFR—brain cancer	6.99e-06	0.000256	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL2—brain cancer	6.94e-06	0.000254	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCND1—brain cancer	6.76e-06	0.000247	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	6.7e-06	0.000245	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MYC—brain cancer	6.68e-06	0.000244	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EGFR—brain cancer	6.53e-06	0.000239	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—VEGFA—brain cancer	6.47e-06	0.000236	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—STAT3—brain cancer	6.4e-06	0.000234	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—VEGFA—brain cancer	6.35e-06	0.000232	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—STAT3—brain cancer	6.28e-06	0.00023	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MYC—brain cancer	5.95e-06	0.000217	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—VEGFA—brain cancer	5.9e-06	0.000216	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TP53—brain cancer	5.87e-06	0.000215	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MYC—brain cancer	5.84e-06	0.000213	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—STAT3—brain cancer	5.84e-06	0.000213	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EGFR—brain cancer	5.82e-06	0.000213	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EGFR—brain cancer	5.71e-06	0.000209	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TP53—brain cancer	5.49e-06	0.0002	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MYC—brain cancer	5.43e-06	0.000198	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EGFR—brain cancer	5.31e-06	0.000194	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TP53—brain cancer	4.89e-06	0.000179	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TP53—brain cancer	4.8e-06	0.000175	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TP53—brain cancer	4.46e-06	0.000163	CbGpPWpGaD
